Akademisyen
BÜŞRA DİNCER
DOÇENT
ONDOKUZ MAYIS ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ ECZACILIK MESLEK BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Farmakoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 34
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
6
Q2
14
Q3
6
Q4
2
WoS (JCR)
Q1
5
Q2
6
Q3
13
Q4
7
TR Index
9
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
2
Ort. yüzdelik
81.4%
Üst %1 payı
0.0%
Üst %10 payı
33.3%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Novel benzenesulfonamides containing a dual triazole moiety with selective carbonic anhydrase inhibition and anticancer activity YÖKSİS SJR Q1 JCR Q2
- 2025 Antagonism of 5‐HT7 Receptors as a Promising Target for Gastric Cancer via Apoptotic Pathway YÖKSİS SJR Q2 JCR Q2 OpenAlex 71.8%
- 2025 The role of urotensin II in the pathogenesis of adenoid hypertrophy YÖKSİS SJR Q3 JCR Q4
- 2025 Multitarget inhibition of diabetic enzymes by thiazole carboxylic acids: experimental and computational approaches YÖKSİS SJR Q1 JCR Q1
- 2025 Protective effects of engeletin on doxorubicin-induced cardiotoxicity via NF-κB/iNOS and Cyt-c/CASP-3 signaling pathways YÖKSİS TR Index JCR Q4
- 2024 Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 98.0%
- 2024 Bioactivity, cytotoxicity, and molecular modeling studies of novel sulfonamides as dual inhibitors of carbonic anhydrases and acetylcholinesterase YÖKSİS SJR Q1 JCR Q1
- 2024 Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies YÖKSİS SJR Q1 JCR Q1
- 2024 Temporal assessment of gadolinium deposition and T1 signal intensity changes in rat kidney with single and multiple doses of injection: An experimental study YÖKSİS TR Index SJR Q3 JCR Q2
- 2023 Gossypin mitigates oxidative damage by downregulating the molecular signaling pathway in oleic acid‐induced acute lung injury YÖKSİS SJR Q4 JCR Q3
- 2023 Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors YÖKSİS SJR Q2 JCR Q2
- 2023 Novel beta-lactam substituted benzenesulfonamides: in vitro enzyme inhibition, cytotoxic activity and in silico interactions YÖKSİS SJR Q2 JCR Q2
- 2023 Discovery of novel benzenesulfonamides incorporating 1,2,3-triazole scaffold as carbonic anhydrase I, II, IX, and XII inhibitors YÖKSİS SJR Q1 JCR Q1
- 2023 Antipsychotics induced reproductive toxicity by stimulating oxidative stress: A comparative in vivo and in silico study YÖKSİS SJR Q2 JCR Q3
- 2023 Unlocking synergistic potential: Agomelatine enhances the chemotherapeutic effect of paclitaxel in breast cancer cell through MT1 melatonin receptors and ER‐alpha Axis YÖKSİS SJR Q2 JCR Q3
- 2023 Otoprotective mechanisms of carvone as an antioxidant agent against ototoxic damage caused by paclitaxel YÖKSİS TR Index JCR Q4
- 2023 Jaceosidin protects L929 fibroblast cells by down-regulation of proinflammatory cytokines and attenuation of oxidative stress-induced impairment of cell proliferation and migration YÖKSİS TR Index
- 2023 Zingiberene attenuates paclitaxel-induced ototoxicity by strengthening cochlear antioxidant defense system in vivo YÖKSİS TR Index SJR Q3 JCR Q4
- 2022 Roflumilast as a potential therapeutic agent for cecal ligation and puncture-induced septic lung injury YÖKSİS SJR Q2 JCR Q3
- 2022 Protective effects of idebenone against sepsis induced acute lung damage YÖKSİS SJR Q2 JCR Q3